Cargando…

Cardiopulmonary dysfunction in patients with limb‐girdle muscular dystrophy 2A

Introduction: Little is known about the frequency of cardiopulmonary failure in limb‐girdle muscular dystrophy type 2A (calpainopathy) patients, although some studies have reported severe cardiomyopathy or respiratory failure. Methods: To clarify the frequency of cardiopulmonary dysfunction in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori‐Yoshimura, Madoka, Segawa, Kazuhiko, Minami, Narihiro, Oya, Yasushi, Komaki, Hirohumi, Nonaka, Ikuya, Nishino, Ichizo, Murata, Miho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396288/
https://www.ncbi.nlm.nih.gov/pubmed/27500519
http://dx.doi.org/10.1002/mus.25369
_version_ 1783230036385464320
author Mori‐Yoshimura, Madoka
Segawa, Kazuhiko
Minami, Narihiro
Oya, Yasushi
Komaki, Hirohumi
Nonaka, Ikuya
Nishino, Ichizo
Murata, Miho
author_facet Mori‐Yoshimura, Madoka
Segawa, Kazuhiko
Minami, Narihiro
Oya, Yasushi
Komaki, Hirohumi
Nonaka, Ikuya
Nishino, Ichizo
Murata, Miho
author_sort Mori‐Yoshimura, Madoka
collection PubMed
description Introduction: Little is known about the frequency of cardiopulmonary failure in limb‐girdle muscular dystrophy type 2A (calpainopathy) patients, although some studies have reported severe cardiomyopathy or respiratory failure. Methods: To clarify the frequency of cardiopulmonary dysfunction in this patient population, we retrospectively reviewed the respiratory and cardiac function of 43 patients with calpainopathy. Results: Nine of the 43 patients had forced vital capacity (FVC) < 80%, and 3 used noninvasive positive pressure ventilation. Mean FVC was significantly lower in patients who were nonambulant and had normal creatine kinase levels. Only 1 patient had a prolonged QRS complex duration. Echocardiography revealed that 1 patient had very mild left ventricular dysfunction. Conclusions: These findings suggest that patients with calpainopathy may develop severe respiratory failure, but cardiac dysfunction is infrequent. Muscle Nerve 55: 465–469, 2017
format Online
Article
Text
id pubmed-5396288
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-53962882017-04-25 Cardiopulmonary dysfunction in patients with limb‐girdle muscular dystrophy 2A Mori‐Yoshimura, Madoka Segawa, Kazuhiko Minami, Narihiro Oya, Yasushi Komaki, Hirohumi Nonaka, Ikuya Nishino, Ichizo Murata, Miho Muscle Nerve Clinical Research Introduction: Little is known about the frequency of cardiopulmonary failure in limb‐girdle muscular dystrophy type 2A (calpainopathy) patients, although some studies have reported severe cardiomyopathy or respiratory failure. Methods: To clarify the frequency of cardiopulmonary dysfunction in this patient population, we retrospectively reviewed the respiratory and cardiac function of 43 patients with calpainopathy. Results: Nine of the 43 patients had forced vital capacity (FVC) < 80%, and 3 used noninvasive positive pressure ventilation. Mean FVC was significantly lower in patients who were nonambulant and had normal creatine kinase levels. Only 1 patient had a prolonged QRS complex duration. Echocardiography revealed that 1 patient had very mild left ventricular dysfunction. Conclusions: These findings suggest that patients with calpainopathy may develop severe respiratory failure, but cardiac dysfunction is infrequent. Muscle Nerve 55: 465–469, 2017 John Wiley and Sons Inc. 2016-12-30 2017-04 /pmc/articles/PMC5396288/ /pubmed/27500519 http://dx.doi.org/10.1002/mus.25369 Text en © 2016 The Authors. Muscle & Nerve Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Research
Mori‐Yoshimura, Madoka
Segawa, Kazuhiko
Minami, Narihiro
Oya, Yasushi
Komaki, Hirohumi
Nonaka, Ikuya
Nishino, Ichizo
Murata, Miho
Cardiopulmonary dysfunction in patients with limb‐girdle muscular dystrophy 2A
title Cardiopulmonary dysfunction in patients with limb‐girdle muscular dystrophy 2A
title_full Cardiopulmonary dysfunction in patients with limb‐girdle muscular dystrophy 2A
title_fullStr Cardiopulmonary dysfunction in patients with limb‐girdle muscular dystrophy 2A
title_full_unstemmed Cardiopulmonary dysfunction in patients with limb‐girdle muscular dystrophy 2A
title_short Cardiopulmonary dysfunction in patients with limb‐girdle muscular dystrophy 2A
title_sort cardiopulmonary dysfunction in patients with limb‐girdle muscular dystrophy 2a
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396288/
https://www.ncbi.nlm.nih.gov/pubmed/27500519
http://dx.doi.org/10.1002/mus.25369
work_keys_str_mv AT moriyoshimuramadoka cardiopulmonarydysfunctioninpatientswithlimbgirdlemusculardystrophy2a
AT segawakazuhiko cardiopulmonarydysfunctioninpatientswithlimbgirdlemusculardystrophy2a
AT minaminarihiro cardiopulmonarydysfunctioninpatientswithlimbgirdlemusculardystrophy2a
AT oyayasushi cardiopulmonarydysfunctioninpatientswithlimbgirdlemusculardystrophy2a
AT komakihirohumi cardiopulmonarydysfunctioninpatientswithlimbgirdlemusculardystrophy2a
AT nonakaikuya cardiopulmonarydysfunctioninpatientswithlimbgirdlemusculardystrophy2a
AT nishinoichizo cardiopulmonarydysfunctioninpatientswithlimbgirdlemusculardystrophy2a
AT muratamiho cardiopulmonarydysfunctioninpatientswithlimbgirdlemusculardystrophy2a